High density lipoprotein-associated miRNA is increased following Roux-en-Y gastric bypass surgery for severe obesity.

high-density lipoprotein functionality intercellular adhesion molecule-1 micro-ribonucleic acid weight loss

Journal

Journal of lipid research
ISSN: 1539-7262
Titre abrégé: J Lipid Res
Pays: United States
ID NLM: 0376606

Informations de publication

Date de publication:
2021
Historique:
received: 08 06 2020
revised: 16 10 2020
pubmed: 24 10 2020
medline: 11 3 2022
entrez: 23 10 2020
Statut: ppublish

Résumé

Roux-en-Y gastric bypass (RYGB) is one of the most commonly performed weight-loss procedures, but how severe obesity and RYGB affect circulating HDL-associated microRNAs (miRNAs) remains unclear. Here, we aim to investigate how HDL-associated miRNAs are regulated in severe obesity and how weight loss after RYGB surgery affects HDL-miRNAs. Plasma HDLs were isolated from patients with severe obesity (n = 53) before and 6 and 12 months after RYGB by immunoprecipitation using goat anti-human apoA-I microbeads. HDLs were also isolated from 18 healthy participants. miRNAs were extracted from isolated HDL and levels of miR-24, miR-126, miR-222, and miR-223 were determined by TaqMan miRNA assays. We found that HDL-associated miR-126, miR-222, and miR-223 levels, but not miR-24 levels, were significantly higher in patients with severe obesity when compared with healthy controls. There were significant increases in HDL-associated miR-24, miR-222, and miR-223 at 12 months after RYGB. Additionally, cholesterol efflux capacity and paraoxonase activity were increased and intercellular adhesion molecule-1 (ICAM-1) levels decreased. The increases in HDL-associated miR-24 and miR-223 were positively correlated with an increase in cholesterol efflux capacity (r = 0.326, P = 0.027 and r = 0.349, P = 0.017, respectively). An inverse correlation was observed between HDL-associated miR-223 and ICAM-1 at baseline. Together, these findings show that HDL-associated miRNAs are differentially regulated in healthy participants versus patients with severe obesity and are altered after RYGB. These findings provide insights into how miRNAs are regulated in obesity before and after weight reduction and may lead to the development of novel treatment strategies for obesity and related metabolic disorders.

Identifiants

pubmed: 33093236
pii: S0022-2275(21)00023-7
doi: 10.1194/jlr.RA120000963
pmc: PMC8010476
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

100043

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.

Auteurs

Jan Hoong Ho (JH)

Lipid Research Group, Division of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom; Cardiovascular Trials Unit, Manchester University NHS Foundation Trust, Manchester, United Kingdom.

Kwok Leung Ong (KL)

Lipid Research Group, School of Medical Sciences, University of New South Wales Sydney, Sydney, Australia.

Luisa F Cuesta Torres (LF)

Lipid Research Group, School of Medical Sciences, University of New South Wales Sydney, Sydney, Australia.

Yifen Liu (Y)

Lipid Research Group, Division of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom.

Safwaan Adam (S)

Lipid Research Group, Division of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom; Cardiovascular Trials Unit, Manchester University NHS Foundation Trust, Manchester, United Kingdom.

Zohaib Iqbal (Z)

Lipid Research Group, Division of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom; Cardiovascular Trials Unit, Manchester University NHS Foundation Trust, Manchester, United Kingdom.

Shaishav Dhage (S)

Lipid Research Group, Division of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom; Cardiovascular Trials Unit, Manchester University NHS Foundation Trust, Manchester, United Kingdom.

Basil J Ammori (BJ)

Department of Surgery, Salford Royal NHS Foundation Trust, Salford, United Kingdom.

Akheel A Syed (AA)

Department of Endocrinology, Salford Royal NHS Foundation Trust, Salford, United Kingdom.

Kerry-Anne Rye (KA)

Lipid Research Group, School of Medical Sciences, University of New South Wales Sydney, Sydney, Australia.

Fatiha Tabet (F)

Lipid Research Group, School of Medical Sciences, University of New South Wales Sydney, Sydney, Australia.

Handrean Soran (H)

Lipid Research Group, Division of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom; Cardiovascular Trials Unit, Manchester University NHS Foundation Trust, Manchester, United Kingdom. Electronic address: hsoran@aol.com.

Articles similaires

Humans Female Middle Aged Gastric Bypass Enteral Nutrition
Humans Pancreaticoduodenectomy Male Female Gastric Bypass

Classifications MeSH